Novo Nordisk As

Denmark · Reporting entity ID 100000000163

Total reported 2019–2025

$490.0M

#37 of 2,960 reporting companies — 0.6% of all reported industry payments

$74.5M in general payments across 5,214 records, plus $415.5M in research funding across 577,159 records.

How it breaks down

General payments $74,522,443

Research funding $415,518,413

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.